Cytokine transcriptome profiling in acute experimental canine atopic dermatitis skin lesions after IL-31 inhibition with lokivetmab.
Chie Tamamoto-MochizukiNatalie CrawfordJordan M EderAndrea J GonzalesThierry OlivryPublished in: Veterinary dermatology (2023)
IL-31 inhibition is insufficient to prevent the expression of other proinflammatory mediators in acute AD and these could be considered as other potential therapeutic targets.